Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term 85622-93-1 (temozolomide). Found 2 abstracts

Gallo JM, Vicini P, Orlansky A, Li S, Zhou F, Ma J, Pulfer S, Bookman MA, Guo P. Pharmacokinetic model-predicted anticancer drug concentrations in human tumors. Clinical Cancer Research. 2004 Dec;10(23):8048-58.
Ma J, Murphy M, O'Dwyer PJ, Berman E, Reed K, Gallo JM. Biochemical changes associated with a multidrug-resistant phenotype of a human glioma cell line with temozolomide-acquired resistance. Biochemical pharmacology. 2002 Apr;63(7):1219-28.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term 85622-93-1 (temozolomide)

4342-03-4 (Dacarbazine) Dacarbazine me [Metabolism] aa [Analogs & Derivatives] 85622-93-1 (temozolomide) 19916-73-5 (O(6)-benzylguanine) 0 (Protein p53) Female ad [Administration & Dosage] Inbred F344 Rats Heterologous Transplantation Phytogenic Antineoplastic Agents Cultured Tumor Cells Predictive Value of Tests Phenotype human) 0 (vascular endothelial growth factor A ph [Physiology] Ovarian Neoplasms [Pharmacokinetics] pd [Pharmacology] Nude Rats Phytogenic) 0 (Antineoplastic Agents Cyclins de [Drug Effects] 0 (Proto-Oncogene Proteins c-bcl-2) Antitumor Drug Screening Assays 0 (DNA-Binding Proteins) Antineoplastic Combined Chemotherapy Protocols tu [Therapeutic Use] Alkylating Antineoplastic Agents DNA Repair Enzymes 0 (cyclin-dependent kinase Inhibitor p21) bi [Biosynthesis] 129298-91-5 (O-(chloroacetylcarbamoyl)fumagillol) Cell Cycle human) EC 3-6-1 (PMS2 protein Proto-Oncogene Proteins c-bcl-2 EC 3-6-1-3 (Adenosinetriphosphatase) Carboplatin 0 (Antineoplastic Combined Chemotherapy Protocols) Topotecan EC 2-1-1-63 (O(6)-Methylguanine-DNA Methyltransferase) Drug Interactions Biological Models Glioma O(6)-Methylguanine-DNA Methyltransferase Sesquiterpenes Paclitaxel Guanine Alkylating) 0 (Antineoplastic Agents pa [Pathology] DNA-Binding Proteins 0 (Cyclins) Multiple Drug Resistance Computer Simulation pk 0 (Neoplasm Proteins) 41575-94-4 (Carboplatin) Neoplasm Proteins Protein p53 dt [Drug Therapy] Vascular Endothelial Growth Factor A EC 6-5-1 (DNA Repair Enzymes) 123948-87-8 (Topotecan) Brain Neoplasms 0 (Vascular Endothelial Growth Factor A) Adenosinetriphosphatase Male 0 (Sesquiterpenes) Rats 73-40-5 (Guanine) Doxorubicin 33069-62-4 (Paclitaxel) 23214-92-8 (Doxorubicin) mammalian) 0 (MLH1 protein
Last updated on Thursday, April 02, 2020